| Alkaline phosphatase (ALP) |
1,556 U/L |
572 U/L |
| ALP isoenzymes |
Liver 76%, bone 24%, intestinal 0%, and placental 0% |
N/A |
| Aspartate aminotransferase (AST) |
172 U/L |
41 U/L |
| Alanine aminotransferase (ALT) |
210 U/L |
66 U/L |
| Total bilirubin |
1.9 mg/dL |
1.3 mg/dL |
| Total protein |
7.7 g/dL |
5.9 g/dL |
| Albumin |
3.8 g/dL |
3.1 g/dL |
| Globulin |
3.9 g/dL |
2.8 g/dL |
| International normalized ratio (INR) |
0.92 s |
< 0.89 s |
| Alpha-fetoprotein (AFP) |
2.1 ng/mL |
N/A |
| Gamma-glutamyl transferase (GGT) |
545 U/L |
N/A |
| Carcinoembryonic antigen (CEA) |
< 0.5 ng/mL |
N/A |
| Liver fibrosis serum panel |
Score: 0.73, stage: F3/F4 advanced fibrosis |
N/A |
| Vitamin D (1,25(OH)D) |
> 156 pg/mL |
N/A |
| Model for end-stage liver disease sodium (MELD-Na) |
11 points |
9 points |
| Bronchoalveolar lavage (BAL) cell count |
Macrophages 93%, neutrophils 1%, eosinophils 1%, and lymphocytes 6% |
N/A |
